National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures taken to help ensure the safety of the final therapies.
All donors who test "reactive" for the viral agents for HIV, HBV and HCV are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada.
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
Registration now open for the 2015 Plasma Protein Forum! +
Highlights from IPPC 2015 +
IPPC Opening Session kicked off with a panel featuring Dr. Paolo Marcucci, Dr. Giuliano Grazzini, Dr. Lorenzo Montrasio, and Patrick Robert. PPTA’s Chairman of the Global Board of Directors, Dr. Marcucci highlighted the Association’s mission “to promote the availability of and access to safe and effective plasma protein therapies for all patients in the world.”Read More
PPTA Recognizes 8th Annual International Rare Disease Day +
The Plasma Protein Therapeutics Association joins more than 300 organizations in 56 countries in recognizing the 8th annual International Rare Disease Day on February 28.
Sponsored by the National Organization of Rare Disorders and Rare Diseases Europe, Rare Diseases Day seeks to raise awareness among the general public and policymakers about rare diseases, impacting lives all over the globe.Read More
PPTA Standards Programs